Skip to main content
. 2015 Jan 6;187(1):23–32. doi: 10.1503/cmaj.140772

Table 3:

External validation of clinical prediction rules in terms of diagnostic accuracy and use of rapid antigen detection testing (n = 676)

Clinical prediction rule Area under the ROC curve of the score (95% CI) Diagnostic accuracy of the rules-based strategy Rapid antigen detection testing*


Sensitivity, % (95% CI) Specificity, % (95% CI) C–index (95% CI) % (95% CI) p value
Breese39 0.60 (0.55–0.64) 88 (84–92) 82 (78–86) 0.85 (0.82–0.88) 76 (73–80) 0.01

Wald42 0.58 (0.53–0.62) 94 (91–97) 63 (58–68) 0.78 (0.76–0.81) 65 (61–69) < 0.001

Edmond38 NA 66 (61–72) 86 (82–89) 0.76 (0.73–0.79) 48 (44–52) < 0.001

McIsaac40 0.56 (0.52–0.60) 94 (92–97) 54 (49–59) 0.74 (0.71–0.77) 52 (48–56) < 0.001

Attia43 0.62 (0.58–0.66) 87 (83–91) 88 (85–91) 0.87 (0.85–0.90) 86 (84–89) 0.99

Joachim37 0.59 (0.55–0.63) 88 (84–92) 40 (35–45) 0.64 (0.61–0.67) 24 (21–27) < 0.001

Note: CI = confidence interval, NA = not available.

*

Use of rapid antigen detection testing corresponds to the number of patients that would undergo testing after the application of the clinical prediction rule.

One-sided exact binomial probability test of whether absolute use of rapid antigen detection testing was < 80%.